{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:12:49Z","timestamp":1790190769922,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,3,31]],"date-time":"2012-03-31T00:00:00Z","timestamp":1333152000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s10875-012-9685-0","type":"journal-article","created":{"date-parts":[[2012,3,30]],"date-time":"2012-03-30T01:22:07Z","timestamp":1333070527000},"page":"975-983","source":"Crossref","is-referenced-by-count":47,"title":["Changes of Treg-Associated Molecules on CD4+CD25+Treg Cells in Myasthenia Gravis and Effects of Immunosuppressants"],"prefix":"10.1007","volume":"32","author":[{"given":"Wen-Hua","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Mei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Shan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Cai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bang-Sheng","family":"Din","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Bo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-Hai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,31]]},"reference":[{"key":"9685_CR1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1196\/annals.1254.026","volume":"998","author":"H Shiono","year":"2003","unstructured":"Shiono H, Roxanis I, Zhang W, Sims GP, Meager A, Jacobson LW, et al. Scenarios for autoimmunization of T and B cells in myasthenia gravis. Ann N Y Acad Sci. 2003;998:237\u201356.","journal-title":"Ann N Y Acad Sci."},{"issue":"10","key":"9685_CR2","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.4049\/jimmunol.174.10.5941","volume":"174","author":"S Po\u00eba-Guyon","year":"2005","unstructured":"Po\u00eba-Guyon S, Christadoss P, Le Panse R, Guyon T, De Baets M, Wakkach A, et al. Effects of cytokines on acetylcholine receptor expression: implications for myasthenia gravis. J Immunol. 2005;174(10):5941\u20139.","journal-title":"J Immunol."},{"issue":"4","key":"9685_CR3","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.surg.2008.11.009","volume":"145","author":"K Bachmann","year":"2009","unstructured":"Bachmann K, Burkhardt D, Schreiter I, Kaifi J, Schurr P, Busch C, et al. Thymectomy is more effective than conservative treatment for myasthenia gravis regarding outcome and clinical improvement. Surgery. 2009;145(4):392\u20138.","journal-title":"Surgery."},{"issue":"2","key":"9685_CR4","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4049\/jimmunol.0802046","volume":"183","author":"C Luther","year":"2009","unstructured":"Luther C, Adamopoulou E, Stoeckle C, Brucklacher-Waldert V, Rosenkranz D, Stoltze L, et al. Prednisolone treatment induces tolerogenic dendritic cells and a regulatory milieu in myasthenia gravis patients. J Immunol. 2009;183(2):841\u20138.","journal-title":"J Immunol."},{"key":"9685_CR5","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/intimm\/dxn044","volume":"20","author":"M Bonelli","year":"2008","unstructured":"Bonelli M, Savitskaya A, von Dalwigk K, Steiner CW, Aletaha D, Smolen JS, et al. Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE). Int Immunol. 2008;20:861\u20138.","journal-title":"Int Immunol."},{"key":"9685_CR6","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.clim.2004.04.005","volume":"112","author":"Y Sun","year":"2004","unstructured":"Sun Y, Qiao J, Lu CZ, Zhao CB, Zhu XM, Xiao BG. Increase of circulating CD4+CD25+ T cells in myasthenia gravis patients with stability and thymectomy. Clin Immunol. 2004;112:284\u20139.","journal-title":"Clin Immunol."},{"key":"9685_CR7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jneuroim.2010.03.016","volume":"225","author":"M Masuda","year":"2010","unstructured":"Masuda M, Matsumoto M, Tanaka S, Nakajima K, Yamada N, Ido N, et al. Clinical implication of peripheral CD4+CD25+ regulatory T cells and Th17 cells in myasthenia gravis patients. J Neuroimmunol. 2010;225:123\u201331.","journal-title":"J Neuroimmunol."},{"key":"9685_CR8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","volume":"55","author":"A Jaretzki 3rd","year":"2000","unstructured":"Jaretzki 3rd A, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, et al. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology. 2000;55:16\u201323.","journal-title":"Neurology"},{"key":"9685_CR9","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1212\/01.WNL.0000163988.28892.79","volume":"64","author":"RS Bedlack","year":"2005","unstructured":"Bedlack RS, Simel DL, Bosworth H, Samsa G, Tucker-Lipscomb B, Sanders DB. Quantitative myasthenia gravis score: Assessment of responsiveness and longitudinal validity. Neurology. 2005;64:1968\u201370.","journal-title":"Neurology."},{"key":"9685_CR10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.trim.2008.09.006","volume":"20","author":"B Zhang","year":"2009","unstructured":"Zhang B, Zhang A, Qu Y, Liu J, Niu Z, Zhao Y. Development of mouse CD4 (+)CD25(+)Foxp3(+) regulatory T cells in xenogeneic pig thymic grafts. Transpl Immunol. 2009;20:180\u20135.","journal-title":"Transpl Immunol."},{"key":"9685_CR11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1189\/jlb.0604341","volume":"78","author":"X Chen","year":"2005","unstructured":"Chen X, Oppenheim JJ, Howard OM. BALB\/c mice have more CD4+CD25+T regulatory cells and show greater susceptibility to suppression of their CD4+CD25- responder T cells than C57BL\/6 mice. J Leukoc Biol. 2005;78:114\u201321.","journal-title":"J Leukoc Biol."},{"key":"9685_CR12","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.4049\/jimmunol.167.3.1245","volume":"167","author":"C Baecher-Allan","year":"2001","unstructured":"Baecher-Allan C, Brown A, Freeman GJ, Hafler DA. CD4+CD25high regulatory cells in human peripheral blood. J Immunol. 2001;167:1245\u201353.","journal-title":"J Immunol."},{"issue":"5","key":"9685_CR13","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1432-2277.2007.00462.x","volume":"20","author":"Z Zhai","year":"2007","unstructured":"Zhai Z, Sun Z, Li Q, Zhang A, Liu H, Xu J, et al. Correlation of the CD4+CD25high T-regulatory cells in recipients and their corresponding donors to acute GVHD. Transpl Int. 2007;20(5):440\u20136.","journal-title":"Transpl Int."},{"key":"9685_CR14","first-page":"563","volume":"34","author":"R Okita","year":"2009","unstructured":"Okita R, Yamaguchi Y, Ohara M, Hironaka K, Okawaki M, Nagamine I, et al. Targeting of CD4+CD25high cells while preserving CD4+CD25low cells with low-dose chimeric anti-CD25 antibody in adoptive immunotherapy of cancer. Int J Oncol. 2009;34:563\u201372.","journal-title":"Int J Oncol."},{"issue":"7129","key":"9685_CR15","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nature05543","volume":"445","author":"MA Gavin","year":"2007","unstructured":"Gavin MA, Rasmussen JP, Fontenot JD, Vasta V, Manganiello VC, Beavo JA, et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature. 2007;445(7129):771\u20135.","journal-title":"Nature."},{"issue":"11","key":"9685_CR16","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1093\/intimm\/dxh165","volume":"16","author":"H Yagi","year":"2004","unstructured":"Yagi H, Nomura T, Nakamura K, Yamazaki S, Kitawaki T, Hori S, et al. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int Immunol. 2004;16(11):1643\u201356.","journal-title":"Int Immunol."},{"issue":"4","key":"9685_CR17","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/eji.200940022","volume":"40","author":"X Chen","year":"2010","unstructured":"Chen X, Subleski JJ, Hamano R, Howard OM, Wiltrout RH, Oppenheim JJ. Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+ regulatory T cells in human peripheral blood. Eur J Immunol. 2010;40(4):1099\u2013106.","journal-title":"Eur J Immunol."},{"key":"9685_CR18","doi-asserted-by":"crossref","first-page":"6435","DOI":"10.4049\/jimmunol.172.10.6435","volume":"172","author":"IM Kleer de","year":"2004","unstructured":"de Kleer IM, Wedderburn LR, Taams LS, Patel A, Varsani H, Klein M, et al. CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol. 2004;172:6435\u201343.","journal-title":"J. Immunol."},{"key":"9685_CR19","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1084\/jem.20060468","volume":"203","author":"N Seddiki","year":"2006","unstructured":"Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, Landay A, et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med. 2006;203:1693\u2013700.","journal-title":"J Exp Med."},{"key":"9685_CR20","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/jid.2009.313","volume":"130","author":"S Klein","year":"2010","unstructured":"Klein S, Kretz CC, Krammer PH, Kuhn A. CD127 (low\/-) and FoxP3 (+) expression levels characterize different regulatory T-cell populations in human peripheral blood. J Invest Dermatol. 2010;130:492\u20139.","journal-title":"J Invest Dermatol."},{"key":"9685_CR21","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-11-3900","volume":"105","author":"A Balandina","year":"2005","unstructured":"Balandina A, L\u00e9cart S, Dartevelle P, Saoudi A, Berrih-Aknin S. Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. Blood. 2005;105:735\u201341.","journal-title":"Blood."},{"issue":"7282","key":"9685_CR22","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nature08750","volume":"463","author":"Y Zheng","year":"2010","unstructured":"Zheng Y, Josefowicz S, Chaudhry A, Peng XP, Forbush K, Rudensky AY. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature. 2010;463(7282):808\u201312.","journal-title":"Nature."},{"key":"9685_CR23","doi-asserted-by":"crossref","first-page":"6736","DOI":"10.4049\/jimmunol.0900498","volume":"182","author":"LL Molinero","year":"2009","unstructured":"Molinero LL, Yang J, Gajewski T, Abraham C, Farrar MA, Alegre ML. CARMA1 controls an early checkpoint in the thymic development of FoxP3+ regulatory T cells. J Immunol. 2009;182:6736\u201343.","journal-title":"J Immunol."},{"key":"9685_CR24","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/intimm\/12.8.1145","volume":"12","author":"Y Kuniyasu","year":"2000","unstructured":"Kuniyasu Y, Takahashi T, Itoh M, Shimizu J, Toda G, Sakaguchi S. Naturally anergic and suppressive CD25(+)CD4(+) T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation. Int Immunol. 2000;12:1145\u201355.","journal-title":"Int Immunol."},{"key":"9685_CR25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.immuni.2011.03.029","volume":"35","author":"D Haribhai","year":"2011","unstructured":"Haribhai D, Williams JB, Jia S, Nickerson D, Schmitt EG, Edwards B, et al. A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity. Immunity. 2011;35:109\u201322.","journal-title":"Immunity."},{"key":"9685_CR26","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/eji.200838346","volume":"38","author":"EN Huter","year":"2008","unstructured":"Huter EN, Punkosdy GA, Glass DD, Cheng LI, Ward JM, Shevach EM. TGF-beta-induced Foxp3+ regulatory T cells rescue scurfy mice. Eur J Immunol. 2008;38:1814\u201321.","journal-title":"Eur. J Immunol."},{"key":"9685_CR27","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.4049\/jimmunol.0904028","volume":"184","author":"AM Thornton","year":"2010","unstructured":"Thornton AM, Korty PE, Tran DQ, Wohlfert EA, Murray PE, Belkaid Y, et al. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol. 2010;184:3433\u201341.","journal-title":"J Immunol."},{"key":"9685_CR28","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.molimm.2010.02.001","volume":"47","author":"D Getnet","year":"2010","unstructured":"Getnet D, Grosso JF, Goldberg MV, Harris TJ, Yen HR, Bruno TC, et al. A role for the transcription factor Helios in human CD4(+)CD25(+) regulatory T cells. Mol Immunol. 2010;47:1595\u2013600.","journal-title":"Mol Immunol."},{"issue":"3","key":"9685_CR29","doi-asserted-by":"crossref","first-page":"976","DOI":"10.4049\/jimmunol.1102964","volume":"188","author":"RA Gottschalk","year":"2012","unstructured":"Gottschalk RA, Corse E, Allison JP. Expression of helios in peripherally induced Foxp3+ regulatory T cells. J Immunol. 2012;188(3):976\u201380.","journal-title":"J Immunol."},{"issue":"8","key":"9685_CR30","doi-asserted-by":"crossref","first-page":"e24226","DOI":"10.1371\/journal.pone.0024226","volume":"6","author":"T Akimova","year":"2011","unstructured":"Akimova T, Beier UH, Wang L, Levine MH, Hancock WW. Helios expression is a marker of T cell activation and proliferation. PLoS One. 2011;6(8):e24226.","journal-title":"PLoS One."},{"key":"9685_CR31","doi-asserted-by":"crossref","first-page":"305859","DOI":"10.1155\/2008\/305859","volume":"2008","author":"W Fujimaki","year":"2008","unstructured":"Fujimaki W, Takahashi N, Ohnuma K, Nagatsu M, Kurosawa H, Yoshida S, et al. Comparative study of regulatory T cell function of human CD25CD4 T cells from thymocytes, cord blood, and adult peripheral blood. Clin Dev Immunol. 2008;2008:305859.","journal-title":"Clin Dev Immunol."},{"key":"9685_CR32","doi-asserted-by":"crossref","unstructured":"Onoe T, Kalscheuer H, Danzl N, Chittenden M, Zhao G, Yang YG, et al. Human natural regulatory T cell development, suppressive function, and postthymic maturation in a humanized mouse model. Immunol. 2011;1;187(7):3895\u2013903.","DOI":"10.4049\/jimmunol.1100394"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-012-9685-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-012-9685-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-012-9685-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T04:32:04Z","timestamp":1561523524000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-012-9685-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,31]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["9685"],"URL":"https:\/\/doi.org\/10.1007\/s10875-012-9685-0","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,31]]}}}